High level ciprofloxacin resistance in Salmonella enterica isolated from blood
R Raveendran1, C Wattal, A Sharma
1Department of Clinical Microbiology, Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi - 110 060, India.
Purpose:
Over the last few years, resistance to ciprofloxacin in Salmonella enterica has become a global concern. The present study was undertaken to find out the susceptibility pattern of Salmonella enterica isolates in our hospital.
Methods:
Blood cultures were done using BacT/ALERT 3D system. The antimicrobial susceptibility testing was carried out by the Kirby-Bauer disc diffusion method using CLSI breakpoints. Minimum inhibitory concentration was determined for ciprofloxacin-resistant strains using E-test and Vitek-1 automated system.
Results:
A total of 25,953 samples of blood culture yielded 431 Salmonella enterica serotype Typhi and 198 serotype Paratyphi A isolates. Twenty-two isolates of serotype Typhi were resistant to ciprofloxacin, while two isolates of Typhi and two Paratyphi A were intermediately susceptible to ciprofloxacin. Ciprofloxacin resistance is 5.6% (24 isolates) among Salmonella enterica serotype Typhi. Ampicillin, chloramphenicol and co-trimoxazole resistance in Salmonella enterica serotype Typhi appears to have decreased to 14.9% (64/431) in comparison to the 27% (55/205) during 2003. All isolates were sensitive to ceftriaxone.
Conclusions:
Ciprofloxacin can no longer be considered as the drug of choice in treating Salmonella infections. While first-line antimicrobials may still have a role to play in the treatment of enteric fever, ceftriaxone remains the sole defence against ciprofloxacin-resistant Salmonella infections.
Insights
Ciprofloxacin resistance in Salmonella Typhi is a growing concern. Ceftriaxone is now the primary treatment for these resistant infections.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Ciprofloxacin resistance in Salmonella enterica is a significant global health issue.
- Understanding local susceptibility patterns is crucial for effective treatment.
Purpose of the Study:
- To determine the antimicrobial susceptibility patterns of Salmonella enterica isolates in a hospital setting.
- To assess the prevalence of ciprofloxacin resistance in Salmonella Typhi and Paratyphi A.
Main Methods:
- Blood cultures analyzed using BacT/ALERT 3D system.
- Antimicrobial susceptibility testing via Kirby-Bauer disc diffusion and CLSI breakpoints.
- Minimum inhibitory concentration determined for resistant strains using E-test and Vitek-1.
Main Results:
- 431 Salmonella Typhi and 198 Salmonella Paratyphi A isolates identified.
- 5.6% of Salmonella Typhi isolates showed ciprofloxacin resistance (22/431).
- All isolates remained susceptible to ceftriaxone, while resistance to older antibiotics like ampicillin, chloramphenicol, and co-trimoxazole has decreased.
Conclusions:
- Ciprofloxacin is no longer the preferred treatment for Salmonella infections.
- Ceftriaxone is the recommended treatment for ciprofloxacin-resistant Salmonella infections.
- While first-line antimicrobials may retain some utility, ceftriaxone offers reliable efficacy against resistant strains.
More Related Videos
09:10Combination of Adhesive-tape-based Sampling and Fluorescence in situ Hybridization for Rapid Detection of Salmonella on Fresh Produce
Published on: October 18, 2010
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
